Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

New GENOmic Predictor for COmplications Risk in Type 2 DIAbetes

NCT06586203 is registered in ClinicalTrials.gov with Optithera as lead sponsor.

NCT NCT06586203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06586203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
New GENOmic Predictor for COmplications Risk in Type 2 DIAbetes
Lead sponsor
Optithera
Phase
Not applicable
Overall status
Recruiting
Start date
August 23, 2024
Completion date
August 23, 2028
Enrollment
2,714 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, diabetes mellitus, type 2, diabetic nephropathy type 2